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D.M. Budreckis, B.A. Byrne, R.E. Pollard, R.B. Rebhun, C.O. Rodriguez Jr, and K.A. Skorupski
Background: Urinary tract infections (UTI) are believed to be common in dogs with transitional cell carcinoma (TCC),
but incidence and contributing factors have not been reported.
Objectives: To determine the frequency and bacterial agents associated with UTI in dogs with TCC and define contribut-
ing factors.
Animals: Eighty-five dogs with a history of urogenital TCC undergoing treatment with chemotherapy that had at least 1
urine culture performed.
Methods: Medical records and culture results were retrospectively reviewed and ultrasound images were reviewed when
available. Clinical factors were evaluated statistically for association with positive culture.
Results: Fifty-five percent (47/85) of dogs had at least 1 positive culture during the course of treatment. Female dogs
(80%, 40/50) were more likely than male dogs (29%, 10/35) to have at least 1 positive culture. Ultrasound examination deter-
mined that female dogs were more likely to have urethral (74%, 31/42) or trigonal tumor involvement (71%, 30/42) com-
pared to male dogs (32%, 9/28 and 43%, 12/28, respectively). The most commonly isolated organisms were Staphylococcus
spp. (23.9%, 29/121) and Escherichia coli (19.8%, 24/121). Dogs with urethral involvement of TCC were significantly more
likely to have at least 1 positive culture than dogs without urethral involvement (75%, 30/40 versus 30%, 9/30).
Conclusions: Urinary tract infection is common in dogs with TCC highlighting the importance of regular monitoring for
bacterial cystitis in dogs with TCC. In addition, clinical factors such as tumor location and sex may be predictive of positive
culture and can help clinicians assess the risk of UTI.
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Canine urinary tract cancer accounts for approxi-mately 1.5–2% of all reported malignancies in dogs
with transitional cell carcinoma (TCC) being most com-
mon.1–5 TCC is believed to have a multifactorial etiology
with risk factors including exposure to pesticides, obes-
ity, female sex, neuter status, and breed.1,2,5–7 Factors
that affect response to treatment include stage at time of
diagnosis and tumor location.2 The majority of urinary
TCC in dogs are intermediate to high grade papillary
infiltrative tumors, commonly found in the trigone, that
ultimately progress to partial or complete obstruction of
the urinary tract.1–3,5 Urinary tract infections (UTI) may
occur when the healthy host defense of the bladder is
altered. TCC may cause a failure of host barriers as a
result of abnormal patterns of voiding, decreased muco-
sal defenses caused by changes in the uroepithelium, and
by decreased antibacterial properties caused by altera-
tions of urine pH or host defense peptides, thereby pre-
disposing to UTI.8–12 Previously, published studies have
shown that underlying illness contributing to immuno-
suppression is a risk factor for development of persistent
or recurrent infections, suggesting that patients with can-
cer, those receiving chemotherapy or both may be at
higher risk of UTI.10,13,14 Possible sequelae to untreated
bacterial UTI include renal failure, pyelonephritis, lower
urinary tract dysfunction, septicemia, prostatitis, disco-
spondylitis, or anemia.8–11,15,16
Although TCC causes functional and anatomic
abnormalities that may perpetuate or predispose to
UTI, the actual incidence of infection in tumor-bearing
dogs is unknown. The objectives of this study were to
determine the distribution, characteristics, and bacterial
isolates of UTI in a population of dogs undergoing
treatment for TCC and to determine whether a correla-
tion exists between UTI development and patient or
tumor variables in this population.
Materials and Methods
Study Population
A search of the University of California, Davis William R. Prit-
chard Veterinary Medical Teaching Hospital (VMTH) medical
record database was conducted for the years 2002–2011. Dogs
were included if they had a confirmed histologic or cytologic diag-
nosis of TCC, were treated with chemotherapy and had at least 1
urine sample cultured. Urine samples obtained postmortem were
excluded from the study. Information obtained from the medical
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records consisted of breed; age at diagnosis; sex; neuter status;
tumor location; number of cultures; culture results including bacte-
rial type(s), numbers, and antibiotic susceptibility data; timing of
cultures related to chemotherapy; and, antibiotic history before
presentation. Tumor location at the time of diagnosis was deter-
mined by review of archived ultrasound images (when available)
and evaluated by a single board-certified veterinary radiologist
(REP), who was unaware of the clinical features and culture
results. Locations were categorized as apical, midbladder, trigone,
prostatic gland, urethral, or some combination of these, and data
from tumors involving >1 location at diagnosis were included in
multiple categories.
Bacterial Isolation, Identification, and Susceptibility
Testing
A 10 lL sample of urine was inoculated on 5% sheep blood
and MacConkey agarsa and agar was incubated at 35°C in the
presence of 5% CO2 and observed daily for bacterial growth. Sam-
ples were considered negative for bacterial growth after 5 days of
incubation. Bacteria were identified using conventional microbio-
logical techniques including colony morphology, hemolysis pat-
tern, Gram stain, tubed media, spot tests, and bacterial
identification strips.b ,17 Criteria for positive culture for each col-
lection method were based on standard published information.10,11
Cultures were considered positive if they yielded ≥1000 colony
forming units/mL in a cystocentesis, surgically obtained, or pros-
tatic aspirate sample; ≥10,000 colony forming units/mL in a cathe-
terized sample; and, ≥100,000 colony forming units/mL for a
voided sample or a sample with unknown collection method. Bac-
terial types and fastidious behavior were grouped by genus. Staph-
ylococcus spp. was subdivided based on coagulase activity.
Escherichia coli was classified based on hemolytic status.
Antimicrobial susceptibility testing was performed by the broth
microdilution method using microtiter plates.c Interpretation of
minimum inhibitory concentrations (MICs) was based on criteria
from the Clinical Laboratory Standards Institute (CLSI).18,19 Dur-
ing the study period, a change in laboratory antimicrobial suscep-
tibility testing and interpretation of bacterial urinary isolates
occurred. Initially, urinary bacterial isolates were tested and results
were interpreted based on estimated urinary antimicrobial concen-
trations rather than plasma concentrations. However, because
these were not criteria utilized by the CLSI and were not compara-
ble to subsequent testing, these results have not been reported or
analyzed in this study.
Statistical Analysis
Bacterial species and tumor location were quantified based on
total frequency determined. A 2-sided Fisher’s exact test was per-
formed to evaluate correlations among patient sex, tumor location,
and UTI history. Neuter status was not taken into account when
categorizing patients by sex because of the low number of intact
patients. Tumor location was assigned based on ultrasonographic
appearance, and statistical analyses included only dogs with
images available for review. Dogs were categorized as having had
≥1 UTI or no confirmed history of UTI. Values of P < 0.05 were




Eighty-five dogs met inclusion criteria. There were 50
females (59%; 3 sexually intact and 47 spayed) and 35
males (41%; 2 sexually intact and 33 neutered). Median
age at the time of diagnosis was 10 years (range, 4–
15 years). The most common breeds were mixed breeds
(20/85, 23%), followed by Labrador retriever (8/85,
9.4%), golden retriever (5/85, 5.8%), German shepherd
(4/85, 4.7%), beagle (4/85, 4.7%), and miniature dachs-
hund (4/85, 4.7%). A total of 30 other breeds were rep-
resented by ≤3 dogs.
Tumor
Pretreatment ultrasound images were available for
review for 70 dogs. Sixty percent (42/70) of dogs had
trigonal involvement, 57% (40/70) had urethral involve-
ment, 71% (20/28) of all males had prostatic involve-
ment, 23% (16/70) had midbladder involvement and
14% (10/70) had apical bladder involvement. Fifty-eight
percent (41/70) of dogs had tumors involving ≥1 loca-
tion at the time of diagnosis. Female dogs were signifi-
cantly more likely to have urethral involvement when
compared to male dogs (74% versus 32%, P = 0.001)
with TCC (Fig 1A). Female dogs also were more likely
to have trigonal involvement when compared to male
dogs (71% versus 43%, P = 0.03; Fig 1B). There was
no correlation between midbladder or apical location
and sex in this population of dogs.
Bacterial Isolation
A total of 238 cultures were performed with a median
of 2 cultures (range, 1–21) per dog. Sixty-nine percent
(164/238) of cultures were obtained by cystocentesis,
14% (33/238) by voiding, 12% (28/238) by catheteriza-
tion, 2% (4/238) were surgically obtained, 3% (8/238)
had an unknown method of collection, and 0.4% (1/
238) was obtained by aspiration of the prostate gland.
Neither the surgically obtained samples nor the pros-
tatic aspirate were positive for bacterial growth. Only 1
sample without known collection method was positive
for bacterial growth. Thirty-five percent (83/238) of all
cultures were positive and 55% (47/85) of dogs had at
least 1 positive culture result. Thirty-three percent (54/
164) of cultures obtained by cystocentesis, 55% (18/33)
of cultures obtained by voiding, and 32% (9/28) of cul-
tures obtained by catheterization had positive culture
results. Voided sample cultures were more likely to be
positive when compared to cystocentesis (P = 0.03)
samples. Positive culture rates were similar between cy-
stocentesis and catheterized collection methods
(P = 1.0). Eighty percent (40/50) of female dogs and
29% (10/35) of male dogs had at least 1 positive cul-
ture. Females were significantly more likely to have at
least 1 positive culture (P = 0.0001; Fig 1C). Sixty-seven
percent of dogs (57/85) had a urine culture obtained
before starting chemotherapy and 25% (14/57) of those
cultures were positive. Sixty-seven percent (56/83) of all
positive samples were recultured. Of these, 30% (17/56)
grew the same organism that initially was found on the
positive culture whereas 28% (16/56) of the repeated
cultures grew a different organism. Fifty-five percent
(31/56) of the cultures were determined to have no
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growth on repeated culture. Thirty-two percent (27/83)
of positive cultures were not retested at the VMTH.
Forty-two of the positive cultures were evaluated for
antibiotic susceptibility using urine MIC cut-offs.
Thirty-two positive cultures were evaluated using serum
MIC cut-offs, and MIC data were not available for 8
positive cultures.
From 83 positive cultures, 123 bacterial isolates were
identified. One culture was mixed and another culture
containing 1 organism was defined as an aerobic gram-
positive, nonspore-forming, rod. These 2 cultures were
excluded from classification of organismal types. The
most common bacterial isolates included Staphylococcus
spp. at 23.9% of isolates; 13.2% (16/121) were coagu-
lase-positive Staphylococcus spp. whereas 10.7% (13/
121) were coagulase-negative Staphylococcus spp.
(Table 1). The next most common genus was E. coli at
19.8% of isolates; 14% (17/121) were nonhemolytic
E. coli and 5.8% (7/121) were hemolytic E. coli. These
results were followed by Streptococcus spp. at 18.2%
(22/121), Enterococcus spp. at 7.4% (9/121), Pseudomo-
nas spp. at 7.4% (9/121), Pasteurella spp. at 5.8% (7/
121), Mycoplasma spp. at 3.3% (4/121), Proteus spp. at
2.5% (3/121), Bacillus spp., Enteric spp., Actinomyces
spp. and Aerococcus spp. each represented 1.7% (2/121)
with 5% of other bacteria (1 each of Haemophilus sp.,
Enterobactor sp., Stenotrophomonas sp., Acinetobacter
sp., Serratia sp., and Corynebium sp.). The total number
of positive cultures with >1 organism was 44.6% (37/
83). One bacterial isolate was found in 55.6% (46/83) of
positive cultures, 33.7% (28/83) of cultures had 2 iso-
lates, 8.4% (7/83) of cultures had 3 isolates, and 1.2%
(1/83) of cultures had 4 isolates. One culture obtained
by cystocentesis was labeled mixed with 3 colonies of
growth. Of the cultures for which MIC data were not
available, 4 contained Streptococcus spp. and 1 each
contained Enteric spp., Pseudomonas spp., Mycoplasma
spp., Staphylococcus spp., and Pasteurella spp. Thirty-
two percent (11/47) of all dogs with at least 1 positive
culture grew an E. coli bacterial isolate (Table 1). This
result was followed by Streptococcus spp. at 27.6% (13/
47), Staphylococcus spp. at 23.4% (11/47), Enterococcus
spp. at 19.1% (9/47), Pseudomonas spp. at 14.9% (7/
47), Pasteurella spp. at 12.8% (6/47), Mycoplasma spp.
at 8.5% (4/47), Proteus spp. at 6.3% (3/47), Bacillus
spp., Enteric spp., Actinomyces spp., and Aerococcus
spp. at 4.3% (2/47). One dog each grew Haemophilus
sp., Enterobactor sp., Stenotrophomonas sp., Acinetobac-
ter sp., Serratia sp., and Corynebacter sp.
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Fig 1. Significant findings of tumor location and lower urinary tract infection in dogs with transitional cell carcinoma. (A) Female dogs were
significantly more likely to have urethral tumor involvement than males with urethral tumor involvement (P = 0.001). (B) Female dogs were
significantly more likely to have trigonal tumor involvement than males with trigonal tumor involvement (P = 0.03). (C) Female dogs were sig-
nificantly more likely to have at least one positive culture than male dogs with a positive culture (P < 0.0001). (D) Dogs with urethral involve-
ment were significantly more likely to have at least one positive culture than dogs without urethral involvement (P = 0.0002).
Table 1. Frequency of bacterial isolates from all posi-
tive cultures and frequency of dogs with positive culture
having cultured specific bacterial organisms.
Bacterial Type % of Isolates
% of Dogs With
At Least One
Positive Culture
Staphylococcus spp. 23.9 23.4
Escherichia coli 19.8 32.0
Streptococcus spp. 18.2 27.6
Enterococcus spp. 7.4 19.1
Pseudomonas spp. 7.4 14.9
Pasteurella spp. 5.8 12.8
Mycoplasma spp. 3.3 8.5
Proteus spp. 2.5 6.3
Bacillus spp. 1.7 4.3
Enteric spp. 1.7 4.3
Actinomyces spp. 1.7 4.3
Aerococcus spp. 1.7 4.3
Other 5.0 12.8
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Seventy-five percent (30/40) of dogs with urethral
involvement, 62% (26/42) of dogs with trigonal tumor
involvement, 56% (9/16) of dogs with midbladder loca-
tion, 40% (4/10) of dogs with apical bladder involve-
ment, and 25% of male dogs with prostatic involvement
(5/20) had at least 1 positive culture. Dogs with urethral
involvement of TCC were significantly more likely to
have at least 1 positive culture than dogs with no ure-
thral involvement (75% versus 30%, P = 0.0002;
Fig 1D). When considering only females, dogs with ure-
thral involvement still were more likely to have at least
1 positive culture than dogs without urethral involve-
ment (P = 0.01). No other correlation was found
between location and positive culture.
Twenty-two dogs had 87 urine cultures obtained after
the laboratory policy change for antimicrobial suscepti-
bility testing and interpretive criteria of urinary isolates.
Twelve of these dogs had at least 1 positive culture
(range, 1–16) and 32 positive cultures from these dogs
had MIC data available for review. Six dogs (50%, 1
male, 5 female) had at least 1 culture with ≥1 organisms
with acquired antibiotic resistance to ≥1 antimicrobial
drugs. One dog had a resistant coagulase-negative
Staphylococcus sp., a resistant coagulase-positive Staph-
ylococcus sp. and Aerococcus sp. This dog had recurrent
resistant infections and had 16 positive cultures over
time containing 5 different genera of bacteria, 3 of
which were resistant to ≥1 antimicrobial drugs. One dog
had Aerococcus sp. One dog had resistant nonhemolytic
E. coli and hemolytic E. coli. Two dogs had hemoly-
tic E. coli. Lastly, 1 dog had a resistant nonhemolytic
E. coli.
Antimicrobial History
A total of 69% (59/85) of dogs had a known history
of systemic antimicrobial administration before diagno-
sis and first culture collection. Drug type was not
known for 9 of these dogs. Both amoxicillin/clavulanic
acid and enrofloxacin each were prescribed to 38%
(19/50) of dogs, cephalexin to 24% (12/50) of dogs,
amoxicillin to 22% (11/50) of dogs, and metronidazole
to 6% (3/50) of dogs. Cefpodoxime, chloramphenicol,
trimethoprim-sulfa, and ciprofloxacin each were pre-
scribed to 2 dogs and 1 dog each received marbofloxa-
cin, orbofloxacin, florfenicol, ampicillin, doxycycline,
nitrofurantoin, and cefovecin. Forty percent (20/50) of
patients had a history of >1 prescribed antibiotic. All 5
of 5 dogs with enrofloxacin-resistant bacteria had a
known history of enrofloxacin administration and 2 of
3 dogs with amoxicillin/clavulanic acid-resistant bacteria
had a known history of amoxicillin/clavulanic acid
administration. Dogs without a known history of anti-
microbial administration were not more likely to have a
positive first culture compared to dogs prescribed a sys-
temic antimicrobial drug (P = 1.0).
Discussion
In our study, positive urine cultures were found to be
common in dogs with TCC. Fifty-five percent of dogs
had at least 1 positive culture result during the course
of treatment. In addition, 25% of dogs that had a urine
culture obtained before starting chemotherapy had posi-
tive results. These findings suggest that all dogs diag-
nosed with TCC undergoing chemotherapy should have
a culture performed before starting treatment and cul-
tures should be repeated regularly throughout treat-
ment. Undiagnosed and untreated UTI can lead to
renal failure, pyelonephritis, lower urinary tract dys-
function, septiciemia, prostatitis, discospondylitis, or
anemia and can, themselves, be life-limiting.9–11,15
Results of our study are consistent with previous
studies with regard to signalment and tumor location in
dogs with TCC. Similar to previous studies, female dogs
were more likely to have TCC of the lower urinary tract
than male dogs (59% versus 41%).20 Causes for this
difference are speculative. Because male dogs have an
increased frequency of urination for territorial marking
as compared with female dogs, this behavior could pro-
vide decreased exposure time of carcinogens to the
uroepithelium for male dogs.2 Female dogs also may
have more direct contact with environmental carcino-
gens based on squatting behavior and higher body fat
accounting for a possible increased risk of sequestration
of lipophilic environmental carcinogens.2 The results of
this study showed the most common locations of tumor
involvement were trigonal (60%) and urethral (57%).
However, 58% of dogs had large tumors that were not
isolated to 1 location at the time of diagnosis, making
initial tumor origin difficult to determine.
We also found female dogs to be significantly more
likely to have urethral and trigonal tumor involvement
than male dogs. Although the reason for this difference
between the sexes is unclear, a previous study found a
similar anatomical difference between the sexes with 26/
57 (46%) female dogs and only 4/35 (11%) male dogs
having urethral tumors.20 Unlike our study, there were
similar frequencies of trigonal involvement between
sexes in that study with 23/57 (40%) female dogs and
13/35 (37%) male dogs having trigonal involvement.20
The previous study used cystoscopy and cystotomy to
interpret tumor location, whereas ultrasonography was
used in our study, suggesting that possible diagnostic
shortcomings alone cannot explain the anatomical dif-
ference in tumor location between sexes. Therefore, it is
unclear if female propensity for urethral and trigonal
tumor location is because of an unknown mechanism
causing a sex-related predilection.
Bacteria were isolated from 35% of all cultures, and
culture results with >1 organism were common at
43.3% of positive cultures. The most common organ-
isms cultured in our study were Staphylococcus spp.,
23.7% followed by E. coli at 19.7% and Streptococcus
spp., 18.2%. In comparison, the most prevalent organis-
mal isolate in the canine urinary tract in previously
published studies was E. coli, ranging from 37 to
55%.15,21 The most likely organisms to invade the uri-
nary tract are thought to be those of the colonic micro-
biotia. When evaluating the total number of dogs rather
than the total number of bacterial isolates, E. coli was
the most common isolate in dogs with at least 1 positive
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culture at 32%, followed by Streptococcus spp. at
27.6% and Staphylococcus spp. at 23.4%. One dog in
our study had 21 cultures performed (18 cystocentesis, 2
voided, and 1 unknown collection method), with a large
proportion of the organisms consisting of Staphylococ-
cus spp. and this case likely skewed results. It is
unknown if the distribution of organisms in this study
is the result of compromised local or systemic host
defenses or a result of previously empirically prescribed
antibiotics. The change in laboratory policy relating to
MIC testing and interpretation made it difficult to fully
explore antibiotic resistance in this population, but 27%
of dogs with cultures collected after the procedural
change and 50% of dogs with positive cultures had at
least 1 organism with acquired antimicrobial resistance.
Although data were collected regarding antibiotic his-
tory before presentation to the VMTH, the dosage, fre-
quency, duration of antimicrobial treatment,
antimicrobial type, or some combination of these often
was not available. More than half of all dogs that pre-
sented to the VMTH previously were prescribed antibi-
otic treatment with 40% having received >1 antibiotic
type. Results also showed no difference in likelihood of
having a positive first culture based on previous antibi-
otic history. Characteristics and actual incidence of
antibiotic-resistant organisms is difficult to ascertain
because of the small population of dogs with urinary
isolate antimicrobial susceptibility information. Both
the bacterial isolates and their susceptibility patterns in
this study might be specific to the western United States
and therefore differences may be found in other regions
of the country. Further study into antibiotic-resistant
infections in dogs with TCC is needed.
The results of this study indicate that patient and
tumor factors such as sex and location of tumor may
indicate likelihood of infection. Seventy-five percent of
dogs with urethral involvement and 62% of dogs with
trigonal tumor involvement were diagnosed with at least
1 UTI during the course of treatment. In addition,
more than half of dogs with a midbladder tumor loca-
tion had a history of UTI. Dogs with urethral tumors
statistically were more likely to have UTI than dogs
with tumor location in another region. This study may
indicate that dogs with tumors closer to the urethra are
more likely to have UTI. Interestingly, only 25% of
males with prostatic involvement were found to have
UTI. Dogs with prostatic tumors might be less likely to
develop UTI, but UTI in dogs with prostatic tumors
also might be more difficult to detect by urine culture
alone. Only 1 dog in this study had a prostatic aspirate
cultured and further study into the utility of this culture
method is necessary.
This study also found that female dogs were signifi-
cantly more likely to have a positive culture (74% com-
pared to male dogs with TCC at 28%). This
information is in agreement with previous studies that
showed female dogs are more likely than males to have
uncomplicated UTI.9,12,22 Although the actual cause is
uncertain, bacteria may be able to gain entrance to the
urinary tract by ascension through the shorter urethra
of female dogs.
The results of this study must be interpreted cau-
tiously, taking into account inherent limitations. One
limitation of this study results from the inclusion of
only dogs undergoing chemotherapy for TCC. This
population was chosen because dogs receiving regular
treatment at the VMTH were more likely to have
repeated urine culture data available for review. Che-
motherapy may cause some immunosuppression that
could predispose to UTI, and these inclusion criteria
may have selected for dogs more likely to develop UTI.
Therefore, these results may not be applicable to dogs
with TCC not receiving chemotherapy. Furthermore,
the impetus for a clinician to submit a urine culture
often was not documented in the medical record.
Whether cultures were performed as a consequence of
clinical signs or for routine screening were unknown.
This study also included only dogs that had at least 1
culture performed during the course of treatment,
potentially resulting in selection bias if clinicians sub-
mitted urine samples for culture because of suspicion of
infection. The clinical signs of UTI and progressive
TCC however are similar, and both may prompt urine
culture thereby decreasing bias. Furthermore, bias may
have been further minimized because it is standard
practice at the VMTH to culture urine before starting
chemotherapy and to culture regularly thereafter in
dogs with TCC. Nonetheless, a future prospective study
assessing the actual incidence of UTI in dogs with TCC
is needed to confirm these findings without the inherent
biases of a retrospective study.
In this study, 69% of cultures were obtained by cy-
stocentesis. Fine-needle aspirates of patients suspected
to have urinary tract TCC historically have been dis-
couraged because of concern about implantation of cells
along the needle tract. Needle tract implantation overall
is considered rare.23 It has been reported that abdomi-
nal wall TCC occurred in 6/367 patients having had
ultrasound-guided fine-needle aspiration of the prostate
gland or urinary bladder.24 This number excluded dogs
that had a previous cystotomy performed. It is common
practice at our institution to collect urine from dogs
with TCC by ultrasound-guided cystocentesis at a loca-
tion as distant from the tumor as possible. The risk and
complications of undiagnosed UTI are thought to be
higher than the risk of tumor seeding. Although the
purpose of this study was not to determine the inci-
dence of needle tract seeding in this population, only 1
dog in the study was known to develop abdominal wall
metastasis secondary to seeding. Furthermore, this dog
was confirmed to have a previous history of a cystoto-
my for surgical resection of bladder TCC. No dogs in
this study were confirmed to have needle tract seeding
secondary to a cystocentesis alone, but, necropsies were
not performed on all dogs after death or euthanasia to
confirm the rate of actual tumor seeding. Although the
majority of cultures in this study were obtained by
cystocentesis (69%), voided cultures (14%) were statisti-
cally more likely to be positive. This finding may indi-
cate the possibility of more false positives, despite the
published organismal cut-offs, or alternatively, may
result from detection of true infections in dogs with
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tumors present in the prostate gland or urethra. Further
study into these findings is necessary.
In conclusion, these results confirm the clinical suspi-
cion that UTI is are common in dogs with TCC with
25% of dogs having a positive culture at diagnosis and
over 50% of dogs having at least 1 positive culture dur-
ing the course of treatment. These results also highlight
the importance of regular monitoring for UTI, includ-
ing relapse and reinfection after treatment of dogs with
TCC. Tumor location and sex were predictive of posi-
tive culture in this study, and may guide a clinician’s
decision as to how aggressively a patient should be
monitored for UTI. Further prospective investigation
into UTI incidence and the relationship between UTI
risk, sex, and tumor location is warranted.
Footnotes
a Hardy Diagnostics, Santa Maria, CA.
b API, bioMerieux, Durham, NC.
c Sensititre, ThermoFisher Scientific, Oakwood Village, OH.
d GraphPad Prism for Windows version 5.0c, GraphPad Software,
San Diego, CA.
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